CompletedNot Applicable

The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)

United States454 participantsStarted 2013-08

Plain-language summary

The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health related quality of life (HRQOL) data on consecutively treated patients with metastatic spine tumors. The objectives are to determine the validity and reliability of the Spine Cancer Outcomes Questionnaire (SCOQ) for use in the assessment of spine tumor outcomes, to determine if the Spine Instability Neoplastic Score (SINS) Classification is a valid tool for predicting the stability of spine in metastatic spine disease, and to determine the efficacy of surgery versus radiotherapy for the treatment of impending instability secondary to metastatic disease of the spine.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signed informed consent * Age between 18 and 75 years * Able to read and write English at an elementary level * Diagnosis of metastatic tumor of the spine Exclusion Criteria: * The primary cancer site is central nervous system or spine * History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening * Is a prisoner * A disease or condition that would, in opinion of the investigator, preclude accurate evaluation (e.g. significant psychiatric disease)

What they're measuring

Change in Spine Cancer Outcomes Questionnaire (SCOQ)

Timeframe: 0, 6, 12, 26, 52 and 104 weeks

Trial details

NCT IDNCT01825161

SponsorAO Foundation, AO Spine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12

View on ClinicalTrials.gov More Secondary Malignant Neoplasm of Vertebral Column trials